Acer Medical Inc. (TPEX:6857)
Taiwan · Delayed Price · Currency is TWD 98.50
+2.50 (2.60%)
May 8, 2026, 9:41 AM CST
Acer Medical Revenue
In the year 2025, Acer Medical had annual revenue of 60.05M TWD with 19.73% growth. Acer Medical had revenue of 30.12M in the half year ending June 30, 2025, with 311.77% growth.
Revenue
60.05M
Revenue Growth
+19.73%
P/S Ratio
24.97
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 60.05M | 9.90M | 19.73% |
| Dec 31, 2024 | 50.16M | 22.71M | 82.73% |
| Dec 31, 2023 | 27.45M | 14.39M | 110.17% |
| Dec 31, 2022 | 13.06M | 3.43M | 35.66% |
| Dec 31, 2021 | 9.63M | 8.61M | 849.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Pharmaceutical | 20.51B |
| PharmaEssentia | 15.63B |
| Cowealth Medical Holding | 2.96B |
| Arich Enterprise | 1.55B |
| GeneFerm Biotechnology | 677.10M |
| GenMont Biotech Incorporation | 401.23M |
| NeoCore Technology | 244.66M |
| InnoPharmax | 68.99M |